Natural immunity to HIV: A delicate balance between strength and control

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Poudrier, Johanne ^a   Thibodeau, Valérie ^a   Roger, Michel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; INNATE IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROSTITUTION; REVIEW; VIRUS RESISTANCE; VIRUS TRANSMISSION; ANIMAL; DISEASE TRANSMISSION; FEMALE; FEMALE GENITAL SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; VIROLOGY;

ANIMALS; FEMALE; GENITALIA, FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; SEX WORKERS;

MLCS; MLOWN;

EID: 84872149493     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/875821     Document Type: Review

References (106)

1. http://www.unaids.org/globalreport/Global-report.htm
2. Schellenberg J. J., Plummer F. A., The microbiological context of HIV resistance: vaginal microbiota and mucosal inflammation at the viral point of entry. International Journal of Inflammation 2012 2012 10 131243 10.1155/2012/131243
3. Moir S., Fauci A. S., B cells in HIV infection and disease. Nature Reviews Immunology 2009 9 4 235 245 2-s2.0-63149142646 10.1038/nri2524
4. Bomsel M., Tudor D., Drillet A. S., Alfsen A., Ganor Y., Roger M. G., Mouz N., Amacker M., Chalifour A., Diomede L., Devillier G., Cong Z., Wei Q., Gao H., Qin C., Yang G. B., Zurbriggen R., Lopalco L., Fleury S., Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 2011 34 2 269 280 2-s2.0-79951754740 10.1016/j.immuni.2011.01.015
5. McElrath M. J., Standing guard at the mucosa. Immunity 2011 34 2 146 148 2-s2.0-79951745043 10.1016/j.immuni.2011.02.014
6. Tomaras G. D., Haynes B. F., Strategies for eliciting HIV-1 inhibitory antibodies. Current Opinion in HIV and AIDS 2010 5 5 421 427 2-s2.0-77955517998 10.1097/COH.0b013e32833d2d45
7. Haynes B. F., Gilbert P. B., McElrath M. J., Immune-correlates analysis of an HIV vaccine efficacy trial. The New England Journal of Medicine 2012 1275 1286
8. Hladik F., McElrath M. J., Setting the stage: host invasion by HIV. Nature Reviews Immunology 2008 8 6 447 457 2-s2.0-44349159423 10.1038/nri2302 (Pubitemid 351735878)
9. Haase A. T., Early events in sexual transmission of hiv and siv and opportunities for interventions. Annual Review of Medicine 2011 62 127 139 2-s2.0-79551578453 10.1146/annurev-med-080709-124959
10. Hickey D. K., Patel M. V., Fahey J. V., Wira C. R., Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. Journal of Reproductive Immunology 2011 88 2 185 194 2-s2.0-79952699341 10.1016/j.jri.2011.01.005
11. Quayle A. J., The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. Journal of Reproductive Immunology 2002 57 1-2 61 79 2-s2.0-0037206403 10.1016/S0165-0378(02)00019-0 (Pubitemid 35245740)
12. Horne A. W., Stock S. J., King A. E., Innate immunity and disorders of the female reproductive tract. Reproduction 2008 135 6 739 749 2-s2.0-45249083217 10.1530/REP-07-0564 (Pubitemid 351837387)
13. Triforiova R. T., Doncel G. F., Fichorova R. N., Polyanionic microbicides modify toll-like receptor-mediated cervicovaginal immune responses7. Antimicrobial Agents and Chemotherapy 2009 53 4 1490 1500 2-s2.0-65749114134 10.1128/AAC.01152-08
14. Gribar S. C., Richardson W. M., Sodhi C. P., Hackam D. J., No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Molecular Medicine 2008 14 9-10 645 659 2-s2.0-55049110418 10.2119/2008-00035.Gribar
15. Den Dunnen J., Gringhuis S. I., Geijtenbeek T. B. H., Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunology, Immunotherapy 2009 58 7 1149 1157 2-s2.0-67349265964 10.1007/s00262-008-0615-1
16. Pala P., Gomez-Roman V. R., Gilmour J., Kaleebu P., An African perspective on mucosal immunity and HIV-1. Mucosal Immunology 2009 2 4 300 314 2-s2.0-67649265310 10.1038/mi.2009.23
17. Shacklett B. L., Immune responses to HIV and SIV in mucosal tissues: 'location, location, location'. Current Opinion in HIV and AIDS 2010 5 2 128 134 2-s2.0-76949085971 10.1097/COH.0b013e328335c178
18. Cerutti A., Puga I., Cols M., Innate control of B cell responses. Trends in Immunology 2011 32 5 202 211 2-s2.0-79955628617 10.1016/j.it.2011.02.004
19. Gaudet R. G., Breden F., Plummer F., Berry J. D., Molecular characterization of the cervical and systemic B-cell repertoire: unique, yet overlapping, immune compartments of an HIV-1 resistant individual. mAbs 2011 3 2 184 194 2-s2.0-79952716667 10.4161/epi.3.2.14858
20. Derby N., Martinelli E., Robbiani M., Myeloid dendritic cells in HIV-1 infection. Current Opinion in HIV and AIDS 2011 6 379 384 2-s2.0-79959941309 10.1097/COH.0b013e3283499d63
21. van der Vlist M., van der Aar A. M. G., Gringhuis S. I., Geijtenbeek T. B. H., Innate signaling in HIV-1 infection of dendritic cells. Current Opinion in HIV and AIDS 2011 6 348 352 2-s2.0-79960000735 10.1097/COH.0b013e328349a2d1
22. Smed-Sörensen A., Loré K., Dendritic cells at the interface of innate and adaptive immunity to HIV-1. Current Opinion in HIV and AIDS 2011 6 405 410 2-s2.0-79959993489 10.1097/COH.0b013e328349b06b
23. + T cells. Current Opinion in HIV and AIDS 2011 2-s2.0-79959946649 10.1097/COH.0b013e328349b0a0
24. Li Q., Estes J. D., Schlievert P. M., Duan L., Brosnahan A. J., Southern P. J., Reilly C. S., Peterson M. L., Schultz-Darken N., Brunner K. G., Nephew K. R., Pambuccian S., Lifson J. D., Carlis J. V., Haase A. T., Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009 458 7241 1034 1038 2-s2.0-67349101763 10.1038/nature07831
25. Bouschbacher M., Bomsel M., Verronèse E., Gofflo S., Ganor Y., Dezutter-Dambuyant C., Valladeau J., Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS 2008 22 11 1257 1266 2-s2.0-49849090482 10.1097/QAD.0b013e3282f736f4
26. Fox C. H., Kotler D., Tierney A., Wilson C. S., Fauci A. S., Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. Journal of Infectious Diseases 1989 159 3 467 471 2-s2.0-0024545655 (Pubitemid 19065893)
27. Asin S. N., Fanger M. W., Wildt-Perinic D., Ware P. L., Wira C. R., Howell A. L., Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. Journal of Infectious Diseases 2004 190 2 236 245 2-s2.0-3242668576 10.1086/421910 (Pubitemid 38951961)
28. Hocini H., Becquart P., Bouhlal H., Chomont N., Ancuta P., Kazatchkine M. D., Bélec L., Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. Journal of Virology 2001 75 11 5370 5374 2-s2.0-0035038397 10.1128/JVI.75.11.5370-5374.2001 (Pubitemid 32448560)
29. Dezzutti C. S., Guenthner P. C., Cummins J. E., Cabrera T., Marshall J. H., Dillberger A., Lal R. B., Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. Journal of Infectious Diseases 2001 183 8 1204 1213 2-s2.0-0035871775 10.1086/319676 (Pubitemid 32281559)
30. + cells: implications for mechanisms of sexual transmission. Journal of Infectious Diseases 2003 188 10 1473 1482 2-s2.0-0346243730 10.1086/379248 (Pubitemid 37523932)
31. Nazli A., Chan O., Dobson-Belaire W. N., Ouellet M., Tremblay M. J., Gray-Owen S. D., Arsenault A. L., Kaushic C., Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathogens 2010 6 4 e1000852 2-s2.0-77953911213 10.1371/journal.ppat.1000852
32. + T cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 39 16776 16781 2-s2.0-70349744046 10.1073/pnas.0907347106
33. Fontenot D., The role of mucosal epithelial cells in HIV infection [Dissertations and Theses] 2010 UT Graduate School of Biomedical Sciences at Houston. http://digitalcommons.library.tmc.edu/utgsbs-dissertations/28
34. Yu H., Tudor D., Alfsen A., Labrosse B., Clavel F., Bomsel M., Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection. Retrovirology 2008 5, article 93 2-s2.0-56849129238 10.1186/1742-4690-5-93
35. + T cells and HIV susceptibility. Current Opinion in HIV and AIDS 2012 7 2 195 202 10.1097/COH.0b013e3283504941
36. + T cell subset coexpressing multiple markers of HIV susceptibility. Journal of Immunology 2011 187 11 6032 6042 10.4049/jimmunol. 1101836
37. + T cells are highly permissive to HIV-1 infection. Journal of Immunology 2010 184 3 1604 1616 2-s2.0-77949320175 10.4049/jimmunol.0903058
38. + T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β 7. Journal of Immunology 2011 186 8 4618 4630 2-s2.0-79955027908 10.4049/jimmunol.1004151
39. + memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunology 2009 2 5 439 449 2-s2.0-69249153068 10.1038/mi.2009.90
40. Brenchley J. M., Paiardini M., Knox K. S., Asher A. I., Cervasi B., Asher T. E., Scheinberg P., Price D. A., Hage C. A., Kholi L. M., Khoruts A., Frank I., Else J., Schacker T., Silvestri G., Douek D. C., Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008 112 7 2826 2835 2-s2.0-53449093632 10.1182/blood-2008-05-159301
41. Favre D., Lederer S., Kanwar B., Ma Z. M., Proll S., Kasakow Z., Mold J., Swainson L., Barbour J. D., Baskin C. R., Palermo R., Pandrea I., Miller C. J., Katze M. G., McCune J. M., Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathogens 2009 5 2 2-s2.0-61449115882 10.1371/journal.ppat.1000295 e1000295
42. Arthos J., Cicala C., Martinelli E., Macleod K., Van Ryk D., Wei D., Xiao Z., Veenstra T. D., Conrad T. P., Lempicki R. A., McLaughlin S., Pascuccio M., Gopaul R., McNally J., Cruz C. C., Censoplano N., Chung E., Reitano K. N., Kottilil S., Goode D. J., Fauci A. S., HIV-1 envelope protein binds to and signals through integrin α 4 β 7, the gut mucosal homing receptor for peripheral T cells. Nature Immunology 2008 9 3 301 309 2-s2.0-39449098115 10.1038/ni1566 (Pubitemid 351267327)
43. Manel N., Unutmaz D., Littman D. R., The differentiation of human TH-17 cells requires transforming growth factor- β and induction of the nuclear receptor ROR γ t. Nature Immunology 2008 9 6 641 649 2-s2.0-44049104564 10.1038/ni.1610 (Pubitemid 351714729)
44. Schutyser E., Struyf S., Van Damme J., The CC chemokine CCL20 and its receptor CCR6. Cytokine and Growth Factor Reviews 2003 14 5 409 426 2-s2.0-0041874886 10.1016/S1359-6101(03)00049-2 (Pubitemid 37099454)
45. Cremel M., Berlier W., Hamzeh H., Cognasse F., Lawrence P., Genin C., Bernengo J. C., Lambert C., Dieu-Nosjean M. C., Delézay O., Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction. Journal of Leukocyte Biology 2005 78 1 158 166 2-s2.0-22144464047 10.1189/jlb.0305147 (Pubitemid 40979954)
46. Iliev I. D., Mileti E., Matteoli G., Chieppa M., Rescigno M., Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunology 2009 2 4 340 350 2-s2.0-67649243735 10.1038/mi.2009.13
47. Rescigno M., Di Sabatino A., Dendritic cells in intestinal homeostasis and disease. The Journal of Clinical Investigation 2009 119 9 2441 2450 2-s2.0-70349208627 10.1172/JCI39134
48. Li Q., Agno J. E., Edson M. A., Nagaraja A. K., Nagashima T., Matzuk M. M., Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genetics 2011 7 10 e1002320 10.1371/journal.pgen.1002320
49. Sharkey D. J., Macpherson A. M., Tremellen K. P., Mottershead D. G., Gilchrist R. B., Robertson S. A., TGF- β mediates proinflammatory seminal fluid signaling in human cervical epithelial cells. Journal of Immunology 2012 189 2 1024 1035 10.4049/jimmunol.1200005
50. Irnidayanti Y., Effect of retinoic acid on fetus reproductive organ mice (Mus musculus) SwissWebster. International Journal of Medical and Biological Sciences 2012 6 223 225
51. Deng L., Shipley G. L., Loose-Mitchell D. S., Stancel G. M., Broaddus R., Pickar J. H., Davies P. J. A., Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. Journal of Clinical Endocrinology and Metabolism 2003 88 5 2157 2163 2-s2.0-0038707598 10.1210/jc.2002-021844 (Pubitemid 36553112)
52. Takahashi T., Eitzman B., Bossert N. L., Walmer D., Sparrow K., Flanders K. C., McLachlan J., Nelson K. G., Transforming growth factors β 1, β 2, and β 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes. Cell Growth and Differentiation 1994 5 9 919 935 2-s2.0-0028030476 (Pubitemid 24275106)
53. Lester R. T., Yao X. D., Ball T. B., McKinnon L. R., Kaul R., Wachihi C., Jaoko W., Plummer F. A., Rosenthal K. L., Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008 22 6 685 694 2-s2.0-41349107635 10.1097/QAD.0b013e3282f4de35 (Pubitemid 351450636)
54. Pandrea I., Sodora D. L., Silvestri G., Apetrei C., Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends in Immunology 2008 29 9 419 428 2-s2.0-49849088558 10.1016/j.it.2008.05.004
55. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006 12 12 1365 1371 2-s2.0-33845532053 10.1038/nm1511 (Pubitemid 44924494)
56. Mandl J. N., Barry A. P., Vanderford T. H., Kozyr N., Chavan R., Klucking S., Barrat F. J., Coffman R. L., Staprans S. I., Feinberg M. B., Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nature Medicine 2008 14 10 1077 1087 2-s2.0-53549103852 10.1038/nm.1871
57. Vermund S. H., Tabereaux P. B., Kaslow R., Textbook of AIDS Medicine 1999
58. Tomescu C., Abdulhaqq S., Montaner L. J., Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clinical and Experimental Immunology 2011 164 2 158 169 2-s2.0-79953804550 10.1111/j.1365-2249.2011.04379. x
59. Boulet S., Kleyman M., Kim J. Y., Kamya P., Sharafi S., Simic N., Bruneau J., Routy J. P., Tsoukas C. M., Bernard N. F., A combined genotype of KIR3DL1 high expressing alleles and HLA-B57 is associated with a reduced risk of HIV infection. AIDS 2008 22 12 1487 1491 2-s2.0-49849102949 10.1097/QAD. 0b013e3282ffde7e
60. Jennes W., Verheyden S., Demanet C., Adjé-Touré C. A., Vuylsteke B., Nkengasong J. N., Kestens L., Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. Journal of Immunology 2006 177 10 6588 6592 2-s2.0-33750802673 (Pubitemid 44715020)
61. Matte C., Lajoie J., Lacaille J., Zijenah L. S., Ward B. J., Roger M., Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 2004 18 3 427 431 2-s2.0-1642300418 10.1097/00002030-200402200-00008 (Pubitemid 38365869)
62. MacDonald K. S., Fowke K. R., Kimani J., Dunand V. A., Nagelkerke N. J. D., Ball T. B., Oyugi J., Njagi E., Gaur L. K., Brunham R. C., Wade J., Luscher M. A., Krausa P., Rowland-Jones S., Ngugi E., Bwayo J. J., Plummer F. A., Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. Journal of Infectious Diseases 2000 181 5 1581 1589 2-s2.0-0034120188 10.1086/315472 (Pubitemid 30387748)
63. Lockett S. F., Robertson J. R., Brettle R. P., Yap P. L., Middleton D., Brown A. J. L., Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission. Journal of Acquired Immune Deficiency Syndromes 2001 27 3 277 280 2-s2.0-0035394093 (Pubitemid 32661970)
64. Liu C., Carrington M., Kaslow R. A., Gao X., Rinaldo C. R., Jacobson L. P., Margolick J. B., Phair J., O'Brien S. J., Detels R., Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. Journal of Infectious Diseases 2003 187 9 1404 1410 2-s2.0-0038555813 10.1086/374394 (Pubitemid 36549685)
65. Dorak M. T., Tang J., Penman-Aguilar A., Westfall A. O., Zulu I., Lobashevsky E. S., Kancheya N. G., Schaen M. M., Allen S. A., Kaslow R. A., Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples. The Lancet 2004 363 9427 2137 2139 2-s2.0-3042607969 10.1016/S0140-6736(04)16505-7 (Pubitemid 38844156)
66. Ball T. B., Ji H., Kimani J., McLaren P., Marlin C., Hill A. V. S., Plummer F. A., Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007 21 9 1091 1101 2-s2.0-34248531947 10.1097/QAD.0b013e3280ef6ae1 (Pubitemid 46763279)
67. Bochud P. Y., Hersberger M., Taffé P., Bochud M., Stein C. M., Rodrigues S. D., Calandra T., Francioli P., Telenti A., Speck R. F., Aderem A., Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007 21 4 441 446 2-s2.0-33847021903 10.1097/QAD. 0b013e328012b8ac
68. Dean M., Carrington M., Winkler C., Genetic restriction of HIV infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 1856 1862
69. Huang Y., Paxton W. A., Wolinsky S. M., Neumann A. U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N. R., Phair J., Ho D. D., Koup R. A., The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine 1996 2 11 1240 1243 2-s2.0-16044367526 10.1038/nm1196-1240 (Pubitemid 26375409)
70. Eugen-Olsen J., Iversen A. K. N., Garred P., Koppelhus U., Pedersen C., Benfield T. L., Sorensen A. M., Katzenstein T., Dickmeiss E., Gerstoft J., Skinhøj P., Svejgaard A., Nielsen J. O., Hofmann B., Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997 11 3 305 310 2-s2.0-8044258978 10.1097/00002030-199703110-00007 (Pubitemid 27086969)
71. De Roda Husman A. M., Koot M., Cornelissen M., Keet I. P. M., Brouwer M., Broersen S. M., Bakker M., Roos M. T. L., Prins M., De Wolf F., Coutinho R. A., Miedema F., Goudsmit J., Schuitemaker H., Association between CCR5 genotype and the clinical course of HIV-1 infection. Annals of Internal Medicine 1997 127 10 882 890 2-s2.0-0007643930 (Pubitemid 27490625)
72. Meyer L., Magierowska M., Hubert J. B., Rouzioux C., Deveau C., Sanson F., Debre P., Delfraissy J. F., Theodorou I., Early protective effect of CCR-5 Δ32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997 11 11 F73 F78 2-s2.0-0030757665 10.1097/00002030-199711000-00001 (Pubitemid 27423287)
73. Zimmerman P. A., Buckler-White A., Alkhatib G., Spalding T., Kubofcik J., Combadiere C., Weissman D., Cohen O., Rubbert A., Lam G., Vaccarezza M., Kennedy P. E., Kumaraswami V., Giorgi J. V., Detels R., Hunter J., Chopek M., Berger E. A., Fauci A. S., Nutman T. B., Murphy P. M., Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Molecular Medicine 1997 3 1 23 36 2-s2.0-8244227329 (Pubitemid 27142522)
74. Michael N. L., Chang G., Louie L. G., Mascola J. R., Dondero D., Birx D. L., Sheppard H. W., The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Medicine 1997 3 3 338 340 2-s2.0-0031041571 10.1038/nm0397-338 (Pubitemid 27112934)
75. Misrahi M., Teglas J. P., N'Go N., Burgard M., Mayaux M. J., Rouzioux C., Delfraissy J. F., Blanche S., CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA 1998 279 4 277 280 2-s2.0-0032573896 10.1001/jama.279.4.277 (Pubitemid 28071017)
76. Bakshi S. S., Zhang L., Ho D., Than S., Pahwa S. G., Distribution of CCR5 δ 32 in human immunodeficiency virus-infected children and its relationship to disease course. Clinical and Diagnostic Laboratory Immunology 1998 5 1 38 40 2-s2.0-0031594461 (Pubitemid 28062943)
77. Smith M. W., Dean M., Carrington M., Contrasting genetic influence of CCR2 and CCR5 variants on HIV infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997 277 959 965
78. Kostrikis L. G., Huang Y., Moore J. P., Wolinsky S. M., Zhang L., Guo Y., Deutsch L., Phair J., Neumann A. U., Ho D. D., A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Medicine 1998 4 3 350 353 2-s2.0-0031915155 10.1038/nm0398-350 (Pubitemid 28144097)
79. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., Nibbs R. J., Freedman B. I., Quinones M. P., Bamshad M. J., Murthy K. K., Rovin B. H., Bradley W., Clark R. A., Anderson S. A., O'Connell R. J., Agan B. K., Ahuja S. S., Bologna R., Sen L., Dolan M. J., Ahuja S. K., The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005 307 5714 1434 1440 2-s2.0-20044377204 10.1126/science.1101160 (Pubitemid 40321934)
80. + patients. Journal of Immunology 2005 174 9 5655 5664 2-s2.0-17844365079 (Pubitemid 40593207)
81. Malim M. H., Bieniasz P. D., HIV restriction factors and mechanisms of evasion. Cold Spring Harbour Perspectives in Medicine 2012 2 5 a006940
82. Laguette N., Benkirane M., How Samhd1 changes our view of viral restriction. Trends in Immunology 2012 33 26 33
83. Mous K., Jennes W., Camara M., Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals. PLoS One 2012 7 e33934 10.1371/journal.pone.0033934
84. Ghosh M., Shen Z., Fahey J. V., Cu-Uvin S., Mayer K., Wira C. R., Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2010 129 2 207 219 2-s2.0-73949143527 10.1111/j.1365-2567.2009.03165.x
85. Ghosh M., Fahey J. V., Shen Z., Lahey T., Cu-Uvin S., Wu Z., Mayer K., Wright P. F., Kappes J. C., Ochsenbauer C., Wira C. R., Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PloS One 2010 5 6 e11366 2-s2.0-77956222058 10.1371/journal.pone.0011366
86. Drannik A. G., Nag K., Yao X.-D., Henrick B. M., Jain S., Blake Ball T., Plummer F. A., Wachihi C., Kimani J., Rosenthal K. L., Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. Journal of Virology 2012 86 8 4599 4610 10.1128/JVI.06561-11
87. Burgener A., Rahman S., Ahmad R., Lajoie J., Ramdahin S., Mesa C., Brunet S., Wachihi C., Kimani J., Fowke K., Carr S., Plummer F., Ball T. B., Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female Sex workers. Journal of Proteome Research 2011 10 11 5139 5149 10.1021/pr200596r
88. Rowland-Jones S. L., Dong T., Fowke K. R., Kimani J., Krausa P., Newell H., Blanchard T., Ariyoshi K., Oyugi J., Ngugi E., Bwayo J., MacDonald K. S., McMichael A. J., Plummer F. A., Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV- resistant prostitutes in Nairobi. The Journal of Clinical Investigation 1998 102 9 1758 1765 2-s2.0-18344418801 (Pubitemid 28516261)
89. + lymphocyte responses in the cervix of HIV- 1-resistant prostitutes in Nairobi. Journal of Immunology 2000 164 3 1602 1611 2-s2.0-17344381593 (Pubitemid 30067280)
90. Kaul R., Trabattoni D., Bwayo J. J., Arienti D., Zagliani A., Mwangi F. M., Kariuki C., Ngugi E. N., MacDonald K. S., Ball T. B., Clerici M., Plummer F. A., HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999 13 1 23 29 2-s2.0-0032989686 10.1097/00002030-199901140-00004 (Pubitemid 29078060)
91. Fowke K. R., Kaul R., Rosenthal K. L., Oyugi J., Kimani J., Rutherford W. J., Nagelkerke N. J. D., Ball T. B., Bwayo J. J., Simonsen J. N., Shearer G. M., Plummer F. A., HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunology and Cell Biology 2000 78 6 586 595 2-s2.0-0033671467 10.1046/j.1440-1711.2000.00944.x
92. Iqbal S. M., Ball T. B., Kimani J., Kiama P., Thottingal P., Embree J. E., Fowke K. R., Plummer F. A., Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. Journal of Infectious Diseases 2005 192 5 728 738 2-s2.0-23944431949 10.1086/432482 (Pubitemid 41193070)
93. + T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. Journal of Infectious Diseases 2005 191 1 20 24 2-s2.0-11144297244 10.1086/425998 (Pubitemid 40041395)
94. Devito C., Hinkula J., Kaul R., Kimani J., Kiama P., Lopalco L., Barass C., Piconi S., Trabattoni D., Bwayo J. J., Plummer F., Clerici M., Broliden K., Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. Journal of Acquired Immune Deficiency Syndromes 2002 30 4 413 420 2-s2.0-0036682591 (Pubitemid 34857316)
95. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. Journal of Experimental Medicine 2007 204 10 2473 2485 2-s2.0-34948906159 10.1084/jem.20070784 (Pubitemid 47529331)
96. + T cells. Blood 2006 107 12 4781 4789 2-s2.0-33646686040 10.1182/blood-2005-12-4818 (Pubitemid 43882629)
97. Pereyra F., Addo M. M., Kaufmann D. E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., Ueda P., Lu Z., Cohen D., Wrin T., Petropoulos C. J., Rosenberg E. S., Walker B. D., Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. Journal of Infectious Diseases 2008 197 4 563 571 2-s2.0-40049094957 10.1086/526786 (Pubitemid 351321534)
98. Bélec L., Ghys P. D., Hocini H., Nkengasong J. N., Tranchot-Diallo J., Diallo M. O., Ettiègne-Traore V., Maurice C., Becquart P., Matta M., Si-Mohamed A., Chomont N., Coulibaly I. M., Wiktor S. Z., Kazatchkine M. D., Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. Journal of Infectious Diseases 2001 184 11 1412 1422 2-s2.0-0035576930 10.1086/324375 (Pubitemid 33108855)
99. Hocini H., Bomsel M., Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. Journal of Infectious Diseases 1999 179 supplement 3 S448 S453 2-s2.0-0032920937 10.1086/314802 (Pubitemid 29198396)
100. Lajoie J., Poudrier J., Massinga-Loembe M., Guédou F., Agossa-Gbenafa C., Labbé A. C., Alary M., Roger M., Differences in immunoregulatory cytokine expression patterns in the systemic and genital tract compartments of HIV-1-infected commercial sex workers in Benin. Mucosal Immunology 2008 1 4 309 316 2-s2.0-45449098302 10.1038/mi.2008.18 (Pubitemid 351850537)
101. Lajoie J., Poudrier J., Massinga Loembe M., Guédou F., Leblond F., Labbé A. C., Alary M., Roger M., Chemokine expression patterns in the systemic and genital tract compartments are associated with HIV-1 infection in women from benin. Journal of Clinical Immunology 2010 30 1 90 98 2-s2.0-77249093942 10.1007/s10875-009-9343-3
102. Fowke K. R., Nagelkerke N. J. D., Kimani J., Simonsen J. N., Anzala A. O., Bwayo J. J., MacDonald K. S., Ngugi E. N., Plummer F. A., Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. The Lancet 1996 348 9038 1347 1351 2-s2.0-0030590749 10.1016/S0140-6736(95) 12269-2 (Pubitemid 26383775)
103. Plummer F. A., Ball T. B., Kimani J., Fowke K. R., Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunology Letters 1999 66 1-3 27 34 2-s2.0-0033046014 10.1016/S0165-2478(98)00182-5 (Pubitemid 29136815)
104. + responses. The Journal of Clinical Investigation 2001 107 3 341 349 2-s2.0-0035134669 (Pubitemid 32157966)
105. + Regulatory T Cells. Journal of Infectious Diseases 2009 199 9 1318 1322 2-s2.0-65649106139 10.1086/597801
106. Ahmed N., Hayashi T., Hasegawa A., Furukawa H., Okamura N., Chida T., Masuda T., Kannagi M., Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. Journal of General Virology 2010 91 11 2804 2813 2-s2.0-78049363385 10.1099/vir.0.022442-0